The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.10BCNY
609.02M · vs all stocks (USD)
Updated Aug 21, 2026
Revenue (TTM)
560.61MCNY
83.37M · vs all stocks (USD)
Updated Aug 21, 2026
Profit Margin
-5.75%
Updated Aug 21, 2026
Beta
0.6360x
vs all stocks
Updated Aug 21, 2026
52-Week Change
-55.95%
vs all stocks
Updated Aug 21, 2026
Market Capitalization
4.10BCNY
609.02M · vs all stocks (USD)
Updated Aug 21, 2026
Enterprise Value
3.42BCNY
508.08M · vs all stocks (USD)
Updated Aug 21, 2026
Forward P/E
17.48x
Updated Aug 21, 2026
Price to Sales (TTM)
6.93x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 7.31×.Updated Aug 21, 2026
Price to Book (MRQ)
2.16x
Updated Aug 21, 2026
Enterprise to Revenue
6.09x
Updated Aug 21, 2026
Enterprise to EBITDA
-181.42x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 91.59×.Updated Aug 21, 2026
Gross Margin
79.73%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 71.43%.Updated Aug 21, 2026
Profit Margin
-5.75%
Updated Aug 21, 2026
Operating Margin
-37.84%
Updated Aug 21, 2026
Return on Assets (TTM)
-1.43%
Updated Aug 21, 2026
Return on Equity (TTM)
-1.29%
Updated Aug 21, 2026
Revenue (TTM)
560.61MCNY
83.37M · vs all stocks (USD)
Updated Aug 21, 2026
Revenue per Share (TTM)
3.29CNYUpdated Aug 21, 2026
Quarterly Revenue Growth
10.10%
Updated Aug 21, 2026
Gross Profit (TTM)
400.44MCNY
59.55M · vs all stocks (USD)
Updated Aug 21, 2026
EBITDA (TTM)
37.31MCNY
5.55M · vs all stocks (USD)
Updated Aug 21, 2026
Net Income (TTM)
-32.25MCNY
-4.80M · vs all stocks (USD)
Updated Aug 21, 2026
Quarterly Earnings Growth (YoY)
-66.98%
Updated Aug 21, 2026
Operating Cash Flow (TTM)
102.54MCNY
15.25M · vs all stocks (USD)
Updated Aug 21, 2026
Levered Free Cash Flow (TTM)
32.58MCNY
4.84M · vs all stocks (USD)
Updated Aug 21, 2026
Payout Ratio
122.93%
Updated Aug 21, 2026
Minority Interest (Equity)
63.00MCNYFY2025 · Dec 31, 2025
Revenue
553.99MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
159.99MCNYFY2025 · Dec 31, 2025
Gross Profit
394.00MCNYFY2025 · Dec 31, 2025
Operating Income
-33.65MCNY
-5.00M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-61.76MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-23.89MCNYFY2025 · Dec 31, 2025
Net Income
-37.87MCNYFY2025 · Dec 31, 2025
EBIT
-61.04MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
37.31MCNYFY2025 · Dec 31, 2025
Research & Development
168.23MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
58.12MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
7.15MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
7.29MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
724.00KCNYFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-37.87MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-5.78MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
77.94MCNYFY2025 · Dec 31, 2025
Free Cash Flow
10.85MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
446.46MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-37.87MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
8.83MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
103.69MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
3.29MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-67.09MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-1.86BCNYFY2025 · Dec 31, 2025
Sale of Investments
1.55BCNYFY2025 · Dec 31, 2025
Other Investing Activity
-1.19MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-384.91MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-12.72MCNYFY2025 · Dec 31, 2025
Other Financing Charges
3.28MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-9.44MCNYFY2025 · Dec 31, 2025
Shares Outstanding
170.51MSharesUpdated Aug 21, 2026
Float Shares
34.24MSharesUpdated Aug 21, 2026
% Held by Insiders
57.49%
vs all stocks
Updated Aug 21, 2026
% Held by Institutions
15.77%
vs all stocks
Updated Aug 21, 2026
Total Cash (MRQ)
782.74MCNY
116.40M · vs all stocks (USD)
Updated Aug 21, 2026
Total Cash per Share (MRQ)
4.59CNYUpdated Aug 21, 2026
Total Debt (MRQ)
5.70MCNY
847.16K · vs all stocks (USD)
Updated Aug 21, 2026
Total Debt to Equity (MRQ)
0.0030x
Updated Aug 21, 2026
Current Ratio (MRQ)
10.39x
Updated Aug 21, 2026
Book Value per Share (MRQ)
10.63CNYUpdated Aug 21, 2026
Total Assets
2.14BCNY
317.87M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.42BCNYFY2025 · Dec 31, 2025
Total Liabilities
239.84MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
722.30MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
46.66MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
193.18MCNYFY2025 · Dec 31, 2025
Cash
446.46MCNYFY2025 · Dec 31, 2025
Cash Equivalents
6.50MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
452.96MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
390.13MCNYFY2025 · Dec 31, 2025
Accounts Receivable
397.13MCNYFY2025 · Dec 31, 2025
Inventory
103.26MCNYFY2025 · Dec 31, 2025
Accounts Payable
65.47MCNYFY2025 · Dec 31, 2025
Short-term Debt
6.18MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
4.02MCNYFY2025 · Dec 31, 2025
Long-term Debt
163.48KCNYFY2025 · Dec 31, 2025
Common Stock (Book)
115.21MCNYFY2025 · Dec 31, 2025
Retained Earnings
200.53MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.90BCNY
282.20M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
65.28MCNYFY2025 · Dec 31, 2025
52-Week Low
20.40CNYUpdated Aug 21, 2026
52-Week High
59.50CNYUpdated Aug 21, 2026
52-Week Change
-55.95%
vs all stocks
Updated Aug 21, 2026
Beta
0.6360x
vs all stocks
Updated Aug 21, 2026
50-Day MA
22.92CNYUpdated Aug 21, 2026
200-Day MA
36.88CNYUpdated Aug 21, 2026
Avg 10-Day Volume
1.22MSharesUpdated Aug 21, 2026
Avg 30-Day Volume
1.41MSharesUpdated Aug 21, 2026
Diluted EPS (TTM)
-0.1900CNYUpdated Aug 21, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.80Profit Margin: -0.06
Financial Health
Altman Z-Score 11.23: safe zoneNotable
Altman Z-Score: 11.23
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Companies that share the same coordination system — how they create, deliver, or capture value.